Jump to content

Desloratadine/pseudoephedrine

From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Desloratadine/pseudoephedrine
Combination of
DesloratadineAntihistamine
PseudoephedrineDecongestant
Clinical data
Trade namesClarinex-D, Aerinaze
AHFS/Drugs.comMicromedex Detailed Consumer Information
License data
Routes of
administration
By mouth
ATC code
Legal status
Legal status
Identifiers
CAS Number
KEGG

Desloratadine/pseudoephedrine, sold under the brand name Clarinex-D among others, is a medication used for the treatment of seasonal allergic rhinitis.[1][2]

Desloratadine/pseudoephedrine was approved for use in the United States in 2005[1][3] and in the European Union in July 2007.[2]

Medical uses

Desloratadine/pseudoephedrine is indicated for the symptomatic treatment of seasonal allergic rhinitis when accompanied by nasal congestion.[2]

References

  1. ^ a b c "Clarinex-D 12 Hour- desloratadine and pseudoephedrine sulfate tablet, extended release". DailyMed. 15 March 2019. Archived from the original on 16 February 2020. Retrieved 1 March 2020.
  2. ^ a b c d "Aerinaze EPAR". European Medicines Agency. 3 August 2007. Archived from the original on 2 March 2020. Retrieved 1 March 2020.
  3. ^ "Drug Approval Package: Clarinex-D 24 Hour (Desloratadine/Pseudoephedrine Sulfate) NDA #021605". U.S. Food and Drug Administration (FDA). 9 May 2007. Archived from the original on 2 March 2020. Retrieved 1 March 2020.

Further reading